What it sells
AI for Pharma Intelligence
Business model breakdown
Buyer: who owns the budget?
UnverifiedPharma/biotech business intelligence and clinical leads (inferred).
Trigger: what makes them buy now?
Drug development takes 15 years and $2B+; teams want faster competitive and landscape research.
Workflow: what inputs become what output?
Search drugs, trials, literature and analyst research, build asset/disease landscapes, trial benchmarking, competitive intelligence, transcribe primary market research interviews.
Distribution: how it reaches customers
Contact sales; trust center.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2024 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.